The gut microbiome is established early in life (176)
So far, fewer than 1% of children and teenagers have taken GLP-1s, but that number is rising quickly
For a more comprehensive tracking system, SeekPeptides offers digital protocol trackers, dose logging tools, and cycle planning guides that automate much of this record-keeping
What the Protocol Architects Are Missing Novo Nordisks Phase 3 program for semaglutide in MDD is underway, and Eli Lilly has initiated exploratory work with tirzepatide in mood disorders following the cardiovascular and metabolic outcomes data from the SURMOUNT and SURPASS trial families
Jung, Y.-H., Kim, H., Kim, H., Kim, E., Baik, J., & Kang, H